LDR | |
01371nam a2200385Ki 4500 |
001 |
|
000733038 |
003 |
|
MiAaHDL |
005 |
|
20090407000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
991022s1976 dcua b 10100 engm |
010 |
⊔ |
⊔ |
‡a 76015416//r852
|
020 |
⊔ |
⊔ |
‡a0841203334
|
035 |
⊔ |
⊔ |
‡asdr-nrlfGLAD184794020-B
|
035 |
⊔ |
⊔ |
‡asdr-miu.990007330380106381
|
035 |
⊔ |
⊔ |
‡aAAI-1805
|
040 |
⊔ |
⊔ |
‡aDLC
‡cDLC
‡dm.c.
‡dCU-I-M
|
090 |
⊔ |
⊔ |
‡a
‡bWG340 A57
|
096 |
⊔ |
⊔ |
‡aQV 150 A629 1976
|
035 |
⊔ |
⊔ |
‡a(OCoLC)2382163
|
245 |
0 |
0 |
‡aAntihypertensive agents :
‡ba symposium sponsored by the Division of Medicinal Chemistry at the 169th meeting of the American Chemical Society, Philadelphia, Penn., April 8, 1975 /
‡cEdward L. Engelhardt, editor
|
260 |
0 |
⊔ |
‡aWashington :
‡bThe Society,
‡c1976
|
300 |
⊔ |
⊔ |
‡avii, 96 p. :
‡bill. ;
‡c24 cm
|
490 |
0 |
⊔ |
‡aACS symposium series ; 27,
‡x0097-6156
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references and index
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aAdrenergic beta blockers
‡xCongresses.
|
650 |
⊔ |
0 |
‡aHypotensive agents
‡xCongresses.
|
700 |
1 |
0 |
‡aEnglehardt, Edward L.,
‡d1919-
|
710 |
2 |
0 |
‡aAmerican Chemical Society.
‡bDivision of Medicinal Chemistry.
|
CID |
⊔ |
⊔ |
‡a000733038
|
DAT |
0 |
⊔ |
‡a20080701085857.0
‡b20090407000000.0
|
DAT |
1 |
⊔ |
‡a20120815184702.0
‡b2023-05-07T18:10:15Z
|
DAT |
2 |
⊔ |
‡a2023-05-07T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-NRLF
‡dLOCAL - GLADIS
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-nrlfGLAD184794020-B
‡auc1
‡bSDR
‡cNRLF
‡puc1.b4333543
‡sUC
‡1GLAD184794020-B
|
974 |
⊔ |
⊔ |
‡bUC
‡cNRLF
‡d20230507
‡sgoogle
‡uuc1.b4333543
‡y1976
‡ric
‡qbib
‡tUS bib date1 >= 1929
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20230802
‡sgoogle
‡umdp.39015003205567
‡y1976
‡ric
‡qbib
‡tUS bib date1 >= 1929
|